Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1958 1
1961 2
1963 2
1965 2
1966 2
1967 1
1968 1
1970 1
1972 1
1973 4
1974 2
1976 2
1978 3
1979 1
1980 6
1981 2
1982 11
1983 6
1984 3
1985 6
1986 4
1987 3
1988 8
1989 6
1990 8
1991 14
1992 14
1993 3
1994 6
1995 2
1996 9
1997 15
1998 10
1999 7
2000 14
2001 13
2002 20
2003 9
2004 21
2005 30
2006 26
2007 31
2008 21
2009 20
2010 33
2011 30
2012 59
2013 39
2014 33
2015 47
2016 53
2017 71
2018 82
2019 79
2020 92
2021 76
2022 73
2023 65
2024 84
2025 87
2026 45

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,270 results

Results by year

Filters applied: . Clear all
Page 1
TAR-200 for Bacillus Calmette-Guérin-Unresponsive High-Risk Non-Muscle-Invasive Bladder Cancer: Results From the Phase IIb SunRISe-1 Study.
Daneshmand S, Van der Heijden MS, Jacob JM, Guerrero-Ramos F, Bögemann M, Simone G, Pieczonka CM, Casco NC, Zainfeld D, Spiegelhalder P, Xylinas E, Cahn D, Lotan Y, Murray KS, Kawahara T, Stromberg K, Martin J, Shukla A, Cutie CJ, Bertzos K, Hampras S, Sweiti H, Necchi A; SunRISe-1 Study. Daneshmand S, et al. Among authors: kawahara t. J Clin Oncol. 2025 Nov 20;43(33):3578-3588. doi: 10.1200/JCO-25-01651. Epub 2025 Jul 30. J Clin Oncol. 2025. PMID: 40737582 Free PMC article. Clinical Trial.
Durvalumab in combination with BCG for BCG-naive, high-risk, non-muscle-invasive bladder cancer (POTOMAC): final analysis of a randomised, open-label, phase 3 trial.
De Santis M, Palou Redorta J, Nishiyama H, Krawczyński M, Seyitkuliev A, Novikov A, Guerrero-Ramos F, Zukov R, Kato M, Kawahara T, Goeman L, Puente J, Hellmis E, Powles T, Radziszewski P, Gust KM, Vasey P, Bigot P, Fradet Y, Hunting J, Armstrong J, Boulos S, Hois S, Shore ND; POTOMAC Investigators. De Santis M, et al. Among authors: kawahara t. Lancet. 2025 Nov 8;406(10516):2221-2234. doi: 10.1016/S0140-6736(25)01897-5. Epub 2025 Oct 17. Lancet. 2025. PMID: 41115436 Clinical Trial.
Wandering consolidation.
Kawahara T, Ochi N, Kato K, Shibamoto K, Nagasaki Y, Nakagawa N, Nakanishi H, Yamane H, Monobe Y, Takigawa N. Kawahara T, et al. Thorax. 2019 Aug;74(8):821-822. doi: 10.1136/thoraxjnl-2018-212059. Epub 2019 May 29. Thorax. 2019. PMID: 31142618 Free PMC article. No abstract available.
The combined inhibition of SLC1A3 and glutaminase in osimertinib-resistant EGFR mutant cells.
Ochi N, Miyake N, Takeyama M, Yamane H, Fukazawa T, Nagasaki Y, Kawahara T, Ichiyama N, Kosaka Y, Mimura A, Nakanishi H, Hiraki A, Kiura K, Takigawa N. Ochi N, et al. Among authors: kawahara t. Biochim Biophys Acta Gen Subj. 2024 Oct;1868(10):130675. doi: 10.1016/j.bbagen.2024.130675. Epub 2024 Jul 24. Biochim Biophys Acta Gen Subj. 2024. PMID: 39059510
Comparative transcriptome atlas as an assistive modality for complex classification of rare kidney cancers.
Jikuya R, Johnson TA, Muraoka E, Noguchi G, Maekawa S, Obara W, Numakura K, Habuchi T, Maejima K, Sasagawa S, Kanazashi Y, Lee H, Song WJ, Sasagawa H, Mitome T, Ohtake S, Kawaura S, Iribe Y, Aomori K, Nagasaka H, Tatenuma T, Ueno D, Komeya M, Ito H, Ito Y, Muraoka K, Kawahara T, Furuya M, Kato I, Hamanoue H, Nishiyama A, Tamura T, Baba M, Suda T, Kodama T, Ogawa T, Uemura H, Yao M, Tsuzuki T, Nagashima Y, Miura Y, Kimura G, Imoto S, Momozawa Y, Fujii S, Makiyama K, Hasegawa T, Shuch BM, Ricketts CJ, Schmidt LS, Linehan WM, Nakagawa H, Hasumi H. Jikuya R, et al. Among authors: kawahara t. Nat Commun. 2025 Nov 24;16(1):10340. doi: 10.1038/s41467-025-65303-z. Nat Commun. 2025. PMID: 41285844 Free PMC article.
Retroperitoneal Castleman's Disease.
Shimokihara K, Kawahara T, Kasahara R, Kasuga J, Sugiura S, Tajiri R, Uemura H, Chiba K. Shimokihara K, et al. Among authors: kawahara t. Case Rep Oncol. 2019 Nov 27;12(3):885-889. doi: 10.1159/000504700. eCollection 2019 Sep-Dec. Case Rep Oncol. 2019. PMID: 31911773 Free PMC article.
1,270 results